← All trials
NCT06046937
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2023
- Primary completion
- Jun 30, 2023
- Completion date
- Jul 15, 2023
- First posted
- Sep 21, 2023
- Last posted
- Oct 17, 2023
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Victoriano Luna Medical CenterLead sponsor
- Victoriano Luna Medical CenterReponsible party - principal investigator
- Victoriano Luna Medical CenterSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.